| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Amoxicillin trihydrate (substance) |
Is a |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin measurement |
Component |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing amoxicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxycillin adverse reaction |
Causative agent (attribute) |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to amoxicillin (finding) |
Causative agent (attribute) |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin overdose |
Causative agent (attribute) |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 125mg/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 125mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 125mg/1.25mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 3g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 250mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing amoxicillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 875 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 400mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin with clavulanate potassium |
Is a |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium adverse reaction |
Causative agent (attribute) |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 400mg/57mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 250mg/62.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| médicament contenant amoxicilline et acide clavulanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 200mg/28.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 250mg/62.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 400mg/57mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing amoxicillin and clavulanate potassium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing amoxicillin and clavulanate potassium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin trihydrate 200mg tablet disperdose for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin trihydrate 400mg tablet disperdose for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 600mg tablet for oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 1g/62.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin sodium (substance) |
Is a |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 775mg extended release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Allergy to amoxicillin (finding) |
Causative agent (attribute) |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
3 |
| Amoxicillin and clavulanate |
Is a |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 875 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 875 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Product containing amoxicillin and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin trihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin and clavulanate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 1g/62.5mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 250mg/125mg tablet for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 125mg/sachet powder for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxycillin 3g/sachet powder for conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
|
| Amoxicillin 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 875 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amoxicillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Amoxicillin (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]